Webinars, Pharmaceutical

Understanding the Evolution of Intranasal Vaccines

Intranasal vaccination is a topic of the growing interest, notably in the wake of the SARS-CoV-19 pandemic because of its value for the prevention of respiratory illness. Key advantages of nasal vaccines include their potential to stimulate both a systemic and localized mucosal response – thereby preventing the ingress of pathogens to the lung – and high patient acceptability. These characteristics are of interest for both prophylactic and therapeutic applications but there are challenges to overcome to fully exploit this inherent potential. Intranasal vaccination is still in its infancy.

In this webinar, we review current best practice for the development of intranasal vaccines. We showcase the portfolio of nasal vaccine devices that Aptar Pharma has to offer and formulation strategies for both liquid and powder administration. As leaders in nasal drug delivery with a range of relevant products and support services Aptar Pharma can help nasal vaccine developers advance successfully and speedily towards commercialization.

Watch the webinar on Understanding the Evolution of Intranasal Vaccines
Speaker(s): Nektaria Karavas Julie D. Suman
9 Nov 2022

Learn more about Aptar Pharma Expertise
in Nasal Vaccines

Find Out More About Nasal Vaccines

This Might Also Be of Interest

30 Sep 2024

Cyclosporine – A Micellar Nasal Spray: A Promising Antiviral Solution Against S...

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
3 Jul 2023

Intranasal Vaccination: Rationale, Progress and Challenges

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
15 Jun 2023

Intranasal Delivery of Thin-Film Freeze-Dried Vaccine Powders

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
24 Apr 2023

The Potential and Challenge of Nasal Vaccination

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 4

Request Access

Close

Requesting access to Understanding the Evolution of Intranasal Vaccines.

  • This field is for validation purposes and should be left unchanged.
Back To Top